Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
DUBLIN, Ireland, July 1, 2013 (GLOBE NEWSWIRE) -- Prothena Corporation plc. (Nasdaq:PRTA), a clinical stage biotechnology company focused on the discovery and development of novel antibodies for the potential treatment of a broad range of diseases, announced that Dale Schenk, PhD, the Company’s President and Chief Executive Officer, will be presenting at the Eighth Annual JMP Securities Healthcare Conference on Wednesday, July 10, 2013, at 10:30 AM ET. The conference will be held at the St. Regis in New York.
Help employers find you! Check out all the jobs and post your resume.
